INFU TECH INC
NT 10-K, 1999-09-29
HOME HEALTH CARE SERVICES
Previous: UNITED ARTISTS THEATRE CO, 8-K, 1999-09-29
Next: GREEN TREE FINANCIAL CORP, 8-K, 1999-09-29





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                            COMMISSION FILE NUMBER: 0-21006

                                   FORM 12B-25

                           NOTIFICATION OF LATE FILING


Check One): |X|Form 10-K  |_|Form 20-F  |_|Form 11-K |_|Form 10-Q  |_|Form N-SAR
            For Period Ended:  June 30, 1999
            [] Transition  Report  on Form  10-K
            [] Transition Report on Form 20-F
            [] Transition Report on Form 11-K
            [] Transition Report on Form 10-Q
            [] Transition Report on Form N-SAR
                                 For the Transition Period Ended:_______________
     If the  notification  relates  to a portion of the  filing  checked  above,
     identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Full Name of Registrant:  Infu-Tech, Inc.

Former Name if Applicable:

Address of Principal Executive Office (Street and Number):  910 Sylvan Avenue

City, State and Zip Code:   Englewood Cliffs, N.J.  07632

PART II - RULES 12b-25(b) AND (c)

     If the subject  report could not be filed  without  unreasonable  effort or
     expense and the registrant  seeks relief  pursuant to Rule  12b-25(b),  the
     following should be completed. (Check box if appropriate)


              (a)   The reasons  described in  reasonable  detail in Part III of
                    this  form  could  not be  eliminated  without  unreasonable
                    effort or expense;
    |X|       (b)   The subject annual report,  semi-annual  report,  transition
                    report  on  Form  10-K,  Form  20-F,  11-K or Form N-SAR, or
                    portion thereof,  will be  filed on or  before the fifteenth
                    calendar  day  following  the  prescribed  due date;  or the
                    subject  quarterly  report  or  transition  report  on  Form
                    10-Q,  or  portion  thereof  will be filed on or before  the
                    fifth calendar day following the prescribed due date; and
              (c)   The accountant's statement or other exhibit required by Rule
                    12b-25(c) has been attached if applicable.

PART III - NARRATIVE

     State below in reasonable  detail the reasons why Forms 10-K,  20-F,  11-K,
     10-Q,  N-SAR,  or the transition  report or portion  thereof,  could not be
     filed within the prescribed time period.

     The registrant has operated  without a chief financial  officer for several
     months.  The newly appointed  chief financial  officer is in the process of
     assuming that position. The absence of a chief financial officer and desire
     of the new  chief  financial  officer  to review  the Form  10-K  financial
     information has delayed completion of the Form 10-K.



<PAGE>


PART IV - OTHER INFORMATION

     (1) Name  and telephone  number of  person  to  contact in  regard to  this
         notification

                 Jack Rosen                    201               567-4600
                 (Name)                     (Area Code)       (Telephone Number)
     (2) Have all other periodic  reports  required under Section 13 or 15(d) of
         the Securities Exchange Act of  1934 or  Section 30 of  the  Investment
         Company Act of 1940 during the preceding 12 months or for  such shorter
         period that the  registrant  was required to  file such  report(s) been
         filed? If answer is no identify  reports(s).  |X| Yes  |_| No

     ---------------------------------------------------------------------------
     (3) It is anticipated that any significant change in results  of operations
         from  the  corresponding  period  for  the  last  fiscal  year  will be
         reflected  by the  earning  statements  to  be included  in the subject
         report or portion thereof?                    |X| Yes  |_| No


         The  registrant  expects to  report a loss for the year  ended June 30,
         1999 of approximately $175,000, compared  with  net  income of $196,000
         in the prior year.  The change from the prior  year  resulted primarily
         from  reductions  of  revenues  and  increases  in costs of medical and
         nutritional  products of  slightly  more than  $1,000,000  each, partly
         offset  by  an  approximately  $950,000 reduction  in  personnel costs,
         an   approximately   $600,000  reduction   in   selling,  general   and
         administrative   costs,  a   reduction  of  approximately   $70,000  in
         depreciation   and  amortization   and an  increase  of   approximately
         $190,000 in net other income.
     ---------------------------------------------------------------------------


                                                                               2

<PAGE>

                                 INFU-TECH, INC.
                             -----------------------
                  (Name of Registrant as Specified in Charter)

     has caused this  notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date         September 28, 1999                   By: /s/ Jack Rosen
    -----------------------------------------        ------------------------
                                                    Jack Rosen
                                                    Chairman of the Board



                                                                               3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission